The prolonged impact of swapping non-fermented with fermented dairy products on cardiovascular disease: the ATTICA cohort study (2002-2022)
- PMID: 39567654
- DOI: 10.1038/s41430-024-01543-4
The prolonged impact of swapping non-fermented with fermented dairy products on cardiovascular disease: the ATTICA cohort study (2002-2022)
Abstract
Background/objectives: Scientific evidence suggests that substituting non-fermented with fermented dairy products may confer cardiovascular health benefits. The role of fermented in relation to non-fermented dairy products on 20-year fatal/non-fatal cardiovascular disease (CVD) incidence was examined.
Subjects/methods: In 2001-2002, n = 3042 free-of-CVD men and women from Attica, Greece, were recruited. Dietary assessment was based on a validated semi-quantitative food frequency questionnaire. CVD evaluation was performed in three follow-up time points at 5, 10 and 20 years, in n = 1988 participants (718 cases).
Results: Participants reported >2 servings/day of fermented dairy products had 1.5 times lower risk to develop CVD compared with their lower level of consumption. Multi-adjusted analysis revealed similar cardioprotective properties per 1 serving increase in dairy consumption of fermented dairy products (Hazard Ratio (HR) = 0.82, 95% Confidence Interval (95%CI) (0.58, 0.95)) as well as when the ratios of fermented:total dairy products (0.90, (0.53, 0.95)) and fermented:non-fermented dairy products (0.74, (0.39, 0.92)) were ≥0.76 and ≥2.5, respectively. The associations were more evident in case of impaired inflammation status. Replacing 1 serving of non-fermented with 1 equivalent serving of fermented dairy products reduced CVD risk (0.74, (0.53, 0.92)). Substitution of low-fat with whole-fat yogurt increased CVD risk (1.35, (1.02, 1.58)). Replacing cheese (any kind) with low-fat yogurt reduced CVD risk (all HRs<1) while with whole-fat yogurt no significance was observed.
Conclusions: Shift of guidelines to a daily pattern of dairy intake yet with an inclination towards emphasizing the consumption of fermented products is recommended.
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests. ETHICAL APPROVA: The ATTICA study was approved by the Bioethics Committee of the University of Athens Medical School (#017/1.5.2001).
Similar articles
-
Dairy products, surrogate markers, and cardiovascular disease; a sex-specific analysis from the ATTICA prospective study.Nutr Metab Cardiovasc Dis. 2020 Nov 27;30(12):2194-2206. doi: 10.1016/j.numecd.2020.07.037. Epub 2020 Jul 31. Nutr Metab Cardiovasc Dis. 2020. PMID: 32988722
-
Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk.Eur J Nutr. 2016 Feb;55(1):349-60. doi: 10.1007/s00394-015-0855-8. Epub 2015 Feb 7. Eur J Nutr. 2016. PMID: 25663611
-
Total Fermented Dairy Food Intake Is Inversely Associated with Cardiovascular Disease Risk in Women.J Nutr. 2019 Oct 1;149(10):1797-1804. doi: 10.1093/jn/nxz128. J Nutr. 2019. PMID: 31192363
-
Fermented dairy food and CVD risk.Br J Nutr. 2015 Apr;113 Suppl 2:S131-5. doi: 10.1017/S0007114514002359. Br J Nutr. 2015. PMID: 26148916 Review.
-
Yogurt and dairy product consumption to prevent cardiometabolic diseases: epidemiologic and experimental studies.Am J Clin Nutr. 2014 May;99(5 Suppl):1235S-42S. doi: 10.3945/ajcn.113.073015. Epub 2014 Apr 2. Am J Clin Nutr. 2014. PMID: 24695891 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources